BVT Call 160 PGR/ DE000VM6PAG0 /
6/21/2024 1:51:02 PM | Chg.-0.030 | Bid1:51:02 PM | Ask1:51:02 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.780EUR | -0.62% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 160.00 USD | 6/21/2024 | Call |
GlobeNewswire
2:30 PM
Great Pacific Gold Announces New High-Grade Assays at Comet Discovery Including 4m at 22.3 g/t Gold
GlobeNewswire
2:00 PM
Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndr...
GlobeNewswire
1:00 PM
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and L...
GlobeNewswire
1:00 PM
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDi...
GlobeNewswire
6/13
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
6/12
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
6/12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
6/11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
6/11
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire
6/11
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire
6/10
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
6/10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
6/7
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
6/7
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire
6/6
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...
GlobeNewswire
6/6
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
6/5
The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening
GlobeNewswire
6/5
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...